Peer-reviewedCC BY-NC-NDJU open plus
Time From Medication Order to Administration of Cabazitaxel vs Lutetium-177-PSMA-617 in Patients With Metastatic Castrate-Resistant Prostate Cancer
5 affiliations
- 1Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, ,
- 2Cancer Biostatistics, Huntsman Cancer Institute, University of Utah, ,
- 3Division of Medical Oncology, Department of Internal Medicine, University of Kansas Cancer Center, ,
- 4Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, ,
- 5Division of Hematology and Medical Oncology, Mayo Clinic, ,
Related
- Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics.
- Low-cost simulator for teaching medication administration to infants: a methodological study.
- Administration of Pro Re Nata Medication: A Retrospective Quantitative Study in Mental Health Acute Care Inpatient Units
- Assessing Bias in Medication Administration in Relation to Incarceration History in a New Orleans Student Clinic Population
- Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression
BibTeX
@article{chehade2026time,
title = {{Time From Medication Order to Administration of Cabazitaxel vs Lutetium-177-PSMA-617 in Patients With Metastatic Castrate-Resistant Prostate Cancer}},
author = {Chadi Hage Chehade and Yeonjung Jo and Zeynep Irem Ozay and Georges Gebrael and Nicolas Sayegh and Tanner Hardy and Micah Ostrowski and Ethan G. Murdock and Richard Ji and Vinay Mathew Thomas and Haoran Li and Soumyajit Roy and Benjamin L. Maughan and Irbaz B. Riaz and Neeraj Agarwal and Umang Swami},
journal = {JU open plus},
year = {2026},
month = nov,
url = {https://europepmc.org/article/PMC/PMC13754206},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Time From Medication Order to Administration of Cabazitaxel vs Lutetium-177-PSMA-617 in Patients With Metastatic Castrate-Resistant Prostate Cancer
AU - Chadi Hage Chehade
AU - Yeonjung Jo
AU - Zeynep Irem Ozay
AU - Georges Gebrael
AU - Nicolas Sayegh
AU - Tanner Hardy
AU - Micah Ostrowski
AU - Ethan G. Murdock
AU - Richard Ji
AU - Vinay Mathew Thomas
AU - Haoran Li
AU - Soumyajit Roy
AU - Benjamin L. Maughan
AU - Irbaz B. Riaz
AU - Neeraj Agarwal
AU - Umang Swami
PY - 2026
DA - 2026/11/01
JO - JU open plus
UR - https://europepmc.org/article/PMC/PMC13754206
SN - 2771-554X
ER -